Talphera (TLPH) Acquisitions (2021 - 2022)

Talphera (TLPH) recorded quarterly Acquisitions of $531000.0 in Q2 2022, down 54.07% quarter-over-quarter from $1.2 million in Q1 2022.

Talphera (TLPH) Acquisitions (2021 - 2022) Analysis & Trends

Talphera's Acquisitions history runs 2 years deep, the most recent figure standing at $531000.0 for Q2 2022.

In Q2 2022, Acquisitions changed N/A year-over-year to $531000.0; the TTM figure through Mar 2023 stood at $531000.0 (down 73.14% YoY), while the FY2022 annual figure was $1.7 million, up 105.48% from the prior year.
Acquisitions was $531000.0 for Q2 2022 at Talphera, down from $1.2 million in the prior quarter.
In the past five years, Acquisitions ranged from a high of $1.2 million in Q1 2022 to a low of $531000.0 in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	-
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	-
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	-
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	-
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	-
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	2.09 Bn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	137.87 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	-
10	Talphera	56.42 Mn	56.42 Mn	-	-

Download Data